<table id="id_c89884cd-cf1b-4647-ac5e-8147c549766e" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_bc4394d5-aa2e-411e-aaa4-82066a4366fb">Table 14. Mean<footnote id="id-a9437e6b-74f6-40e9-be13-9a7720446903">The majority of parameter means determined in each study had coefficients of variation between 20% and 40% for half-life and Cl/F and between 30% and 70% for T<sub>max</sub>. The overall mean values were calculated from individual study means that were weighted based on the number of volunteers/patients in each study. The numbers in parentheses below each parameter mean represent the range of individual volunteer/patient values across studies.</footnote> Pharmacokinetic Parameters in Healthy Volunteers and Adult Patients With Epilepsy</caption>
<col align="left" width="40%"></col>
<col align="center" width="15%"></col>
<col align="center" width="15%"></col>
<col align="center" width="15%"></col>
<col align="center" width="15%"></col>
<thead>
<tr id="id_58a491b9-78a7-4bfe-bffa-cf562551a42c" stylecode="Botrule">
<td align="center" stylecode="Lrule Rrule" valign="bottom">Adult Study Population</td>
<td align="left" stylecode="Rrule" valign="middle">Number of Subjects</td>
<td align="left" stylecode="Rrule" valign="top">T<sub>max</sub>: Time of Maximum Plasma Concentration (hr)</td>
<td align="left" stylecode="Rrule" valign="top">t<sub>Â½</sub>: Elimination Half-life (hr)</td>
<td align="left" stylecode="Rrule" valign="top">Cl/F: Apparent Plasma Clearance (mL/min/kg)</td>
</tr>
</thead>
<tbody>
<tr id="id_61940bf1-8023-4522-afba-3e5a0701bd57" stylecode="Toprule">
<td align="left" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Healthy volunteers taking no other medications:</content>
</td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
</tr>
<tr id="id_275fef84-0f48-4256-8309-1cf626136e4f">
<td align="left" stylecode="Lrule Rrule" valign="top">Single-dose LAMOTRIGINE</td>
<td align="left" stylecode="Rrule" valign="top">179</td>
<td align="left" stylecode="Rrule" valign="top">2.2<br/>(0.25-12.0)</td>
<td align="left" stylecode="Rrule" valign="top">32.8<br/>(14.0-103.0)</td>
<td align="left" stylecode="Rrule" valign="top">0.44<br/>(0.12-1.10)</td>
</tr>
<tr id="id_125ecffa-f1d9-4f0a-bb4d-e26ee45f96e1">
<td align="left" stylecode="Lrule Rrule" valign="top">Multiple-dose LAMOTRIGINE</td>
<td align="left" stylecode="Rrule" valign="top">36</td>
<td align="left" stylecode="Rrule" valign="top">1.7<br/>(0.5-4.0)</td>
<td align="left" stylecode="Rrule" valign="top">25.4<br/>(11.6-61.6)</td>
<td align="left" stylecode="Rrule" valign="top">0.58<br/>(0.24-1.15)</td>
</tr>
<tr id="id_c0136567-4239-4fd6-a5be-e002e5c8cec3">
<td align="left" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Healthy volunteers taking valproate:</content>
</td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
</tr>
<tr id="id_68350ca7-02fc-4983-b1bf-6ac1cee0d18a">
<td align="left" stylecode="Lrule Rrule" valign="top">Single-dose LAMOTRIGINE</td>
<td align="left" stylecode="Rrule" valign="top">6</td>
<td align="left" stylecode="Rrule" valign="top">1.8<br/>(1.0-4.0)</td>
<td align="left" stylecode="Rrule" valign="top">48.3<br/>(31.5-88.6)</td>
<td align="left" stylecode="Rrule" valign="top">0.30<br/>(0.14-0.42)</td>
</tr>
<tr id="id_b8e3dc92-ab8a-4c93-a4a5-e2c0c7cbdaa1">
<td align="left" stylecode="Lrule Rrule" valign="top">Multiple-dose LAMOTRIGINE</td>
<td align="left" stylecode="Rrule" valign="top">18</td>
<td align="left" stylecode="Rrule" valign="top">1.9<br/>(0.5-3.5)</td>
<td align="left" stylecode="Rrule" valign="top">70.3<br/>(41.9-113.5)</td>
<td align="left" stylecode="Rrule" valign="top">0.18<br/>(0.12-0.33)</td>
</tr>
<tr id="id_57398852-63b2-44a4-bd77-46e797da7f08">
<td align="left" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Patients with epilepsy taking valproate only:</content>
</td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
</tr>
<tr id="id_e32b37b4-aa3a-431b-8a40-d21b480ebf3c">
<td align="left" stylecode="Lrule Rrule" valign="top">Single-dose LAMOTRIGINE</td>
<td align="left" stylecode="Rrule" valign="top">4</td>
<td align="left" stylecode="Rrule" valign="top">4.8<br/>(1.8-8.4)</td>
<td align="left" stylecode="Rrule" valign="top">58.8<br/>(30.5-88.8)</td>
<td align="left" stylecode="Rrule" valign="top">0.28<br/>(0.16-0.40)</td>
</tr>
<tr id="id_5d2bc410-16aa-48a5-a339-ffda7a3e9c06">
<td align="left" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Patients with epilepsy taking carbamazepine, phenytoin, phenobarbital, or primidone<footnote id="id-60459c84-592b-47b9-bc9d-c18507c08f46">Carbamazepine, phenobarbital, phenytoin, and primidone have been shown to increase the apparent clearance of lamotrigine. Estrogen-containing oral contraceptives and rifampin have also been shown to increase the apparent clearance of lamotrigine <content stylecode="italics">[see <linkhtml href="#i4i_interactions_id_680e3344-636c-4d11-98be-7b8d75a1b8ea">Drug Interactions (7)</linkhtml>]</content>.</footnote> plus valproate:</content>
</td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
</tr>
<tr id="id_3500eeef-7f07-48cd-bf5d-24ec9652e143">
<td align="left" stylecode="Lrule Rrule" valign="top">Single-dose LAMOTRIGINE</td>
<td align="left" stylecode="Rrule" valign="top">25</td>
<td align="left" stylecode="Rrule" valign="top">3.8<br/>(1.0-10.0)</td>
<td align="left" stylecode="Rrule" valign="top">27.2<br/>(11.2-51.6)</td>
<td align="left" stylecode="Rrule" valign="top">0.53<br/>(0.27-1.04)</td>
</tr>
<tr id="id_1e556cc2-6178-485f-842e-eeaa006cbbb4">
<td align="left" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Patients with epilepsy taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-60459c84-592b-47b9-bc9d-c18507c08f46"></footnoteref>:</content>
</td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top"></td>
</tr>
<tr id="id_493b7699-9ba4-4ea6-b508-7f75d0dcb980">
<td align="left" stylecode="Lrule Rrule" valign="top">Single-dose LAMOTRIGINE</td>
<td align="left" stylecode="Rrule" valign="top">24</td>
<td align="left" stylecode="Rrule" valign="top">2.3<br/>(0.5-5.0)</td>
<td align="left" stylecode="Rrule" valign="top">14.4<br/>(6.4-30.4)</td>
<td align="left" stylecode="Rrule" valign="top">1.10<br/>(0.51-2.22)</td>
</tr>
<tr id="id_88b35655-fbd4-48ba-881a-1df4854cfc27" stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule" valign="top">Multiple-dose LAMOTRIGINE</td>
<td align="left" stylecode="Rrule" valign="top">17</td>
<td align="left" stylecode="Rrule" valign="top">2.0<br/>(0.75-5.93)</td>
<td align="left" stylecode="Rrule" valign="top">12.6<br/>(7.5-23.1)</td>
<td align="left" stylecode="Rrule" valign="top">1.21<br/>(0.66-1.82)</td>
</tr>
</tbody>
</table>